Th1/Th2 Cytokines in Patients with Graves' Disease with or without Ophthalmopathy
Abstract
About 25-50% of Graves' disease (GD) patients develop thyroid eye diseases, which is associated with inflammatory process and abnormalities in the levels of several cytokines in orbital tissues in GD. The aim of this study was to determine the Th1 and Th2 serum cytokines in patients with GD with or without ophthalmopathy.
Serum levels of cytokines and autoantibodies including Interferon-gamma (IFN-γ),Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-10 (IL-10), TSH receptor autoantibody (TRAb), thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody(TgAb) were measured by enzyme linked immunosorbent assay(ELISA) in 34 patients with GD and in 33 normal controls. Patients were also divided in two subgroups: 18 cases with ophthalmopathy and 16 cases without ophthalmopathy. Cytokine and antibody responses were analyzed in both groups.
Compared with control subjects, patients with GD showed elevated levels of IL-2 and IL-10. IFN-γ levels were lower in patients in comparison to the controls. No significant differences were found between patients and controls regarding the IL-4. There was no statistically significant difference in cytokine levels between those with or without ophthalmopathy.
Quantitative-cytokine analysis demonstrated that a combination of Th1 and Th2 cytokines may contribute to the pathogenesis of GD. These results also indicate that IL-10, but not IL-4, is related to the moderate and severe forms of thyroid associated ophthalmophathy.
1. Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev 1984; 5(2):309-55.
2. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev1993; 14(6):747-93.
3. Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2010; 125(2 Suppl 2):S226-37.
4. Canning MO, Ruwhof C, Drexhage HA. Aberrancies in antigen-presenting cells and T cells in autoimmune thyroid disease. A role in faulty tolerance induction. Autoimmunity 2003; 36(6-7):429-42.
5. Jadali Z, Esfahanian F, Eslami MB, Sanati MH. Serum Antibodies against Hepatitis C Virus in Iranian Patients with Graves' Disease. Iran J Allergy Asthma Immunol 2005; 4(2):91-4.
6. Bednarczuk T, Hiromatsu Y, Inoue Y, Yamamoto K, Wall JR, Nauman J. T-cell-mediated immunity in thyroid- associated ophthalmopathy. Thyroid 2002; 12(3):209-15.
7. Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer. Cytokine 2010; 50(3):229-33.
8. Nielsen CH, Hegedüs L, Rieneck K, Moeller AC, Leslie RG, Bendtzen K. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 2007; 147(2):287-95.
9. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004; 11(4):209-13.
10. Werner SC. Classification of the eye changes of Graves' disease. Am J Ophthalmol 1969; 68(4):646-8.
11. Burek CL. Autoimmune thyroiditis research at Johns Hopkins University. Immunol Res 2010; 47(1-3):207-15.
12. Lichiardopol C, Moţa M. The thyroid and autoimmunity.Rom J Intern Med 2009; 47(3):207-15.
13. Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 2008; 18(9):953-8.
14. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B. Prevention of autoantibody- mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J Immunol 2003; 170(7):3522-7.
15. McLachlan SM, Nagayama Y, Rapoport B. Insight into Graves' hyperthyroidism from animal models. Endocr Rev 2005; 26(6): 800-32.
16. Heufelder AE. Pathogenesis of Graves' ophthalmopathy:recent controversies and progress. Eur J Endocrinol 1995;132(5):532-41.
17. de Carli M, D'Elios MM, Mariotti S, Marcocci C, Pinchera A, Ricci M, et al. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 1993; 77(5):1120-4.
18. Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest 1994;93(6):2738-43.
19. Han R, Smith TJ.T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology 2006; 147(1):13-9.
20. Heufelder AE, Bahn RS. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993;23(1):10-7.
21. Hiromatsu Y, Yang D, Bednarczuk T, Miyake I, Nonaka K, Inoue Y. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2000;85(3):1194-9.
22. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984;91(11):1411-9.
23. Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, et al. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 2000; 143(2):197-202.
24. Wakelkamp IM, Gerding MN, Van Der Meer JW, Prummel MF, Wiersinga WM. Both Th1- and Th2- derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 2000; 121(3): 453-7.
25. Komorowski J, Jankiewicz J, Robak T, Błasińska- Morawiec M, Stepień H. Cytokines serum levels as the markers of thyroid activation in Graves' disease.Immunol Lett 1998; 60(2-3):143-8.
26. Tang L, Luo Q, Zhou X, Xia R. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy]. Zhonghua Yan Ke Za Zhi 2002;38(3):165-7
27. Corrales JJ, Orfao A, López A, Mories MT, Miralles JM, Ciudad J. Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves' disease: relationship with disease activity. Cytometry 1997; 30(3):118-23.
28. Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charreire J, Nicoletti F.The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol 1993;23(1):275-8.
29. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 2002;168(5):2470-4.
30. Tang H, Sharp GC, Peterson KP, Braley-Mullen H. IFN- gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids. J Immunol 1998; 160(10):5105-12.
31. Alimi E, Huang S, Brazillet MP, Charreire J.Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-gamma receptor gene. Eur J Immunol 1998; 28(1) :201-8.
32. Vladutiu AO, Sulkowski E.Inhibition of murine autoimmune thyroiditis by interferon. Biomedicine 1980;33(6):173-4.
33. Iwatani Y, Gerstein HC, Iitaka M, Row VV, Volpé R.Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. J Clin Endocrinol Metab 1986; 63(3):695-708.
34. Matsubayashi S, Akasu F, Kasuga Y, Snow K, Keystone E, Volpé R. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.Clin Exp Immunol 1990; 82(1):63-8.
35. Douglas RS, Gianoukakis AG, Goldberg RA, Kamat S, Smith TJ. Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes. Clin Exp Immunol 2007; 148(1):64-71.
36. Takeoka K, Watanabe M, Matsuzuka F, Miyauchi A, Iwatani Y. Increase of serum interleukin-10 in intractable Graves' disease. Thyroid 2004; 14(3):201-5.
37. Nakamoto Y, Niki M, Watanabe M, Iwatani Y. Increase in immunoglobulin G3-secreting cells in intractable Graves' disease. Thyroid 2003; 13(4):325-31.
38. Nielsen CH, Hegedüs L, Leslie RG. Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens. Eur J Immunol 2004; 34(1):263-72.
39. Nielsen CH, Leslie RG, Jepsen BS, Kazatchkine MD, Kaveri SV, Fischer E. Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol 2001; 31(9):2660-8.
40. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182:68-79.
41. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3(10):944-50.
42. Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004 15; 172(10):6427-34.
43. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40(2):249-60.
44. Fox CJ, Danska JS. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol 1997 1; 158(5):2414-24.
45. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4(5):393-5.
46. Zhang GX, Xiao BG, Yu LY, van der Meide PH, Link H.Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. J Neuroimmunol 2001; 113(1):10-8.
47. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, deVries JE. Interleukin-10. Curr Opin Immunol 1992;4(3):314-20.
48. Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS.Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res 2011;31 (10):721-31.
| Files | ||
| Issue | Vol 12, No 2 (2013) | |
| Section | Articles | |
| Keywords | ||
| Cytokines Graves' disease Ophthalmopathy T-Lymphocytes | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
